A top health care blog is buzzing about a pilot program at Mercy.
In Hospital Impact’s article “Unique device identifiers (UDIs) can save hospitals millions,” Mercy's Dr. Joseph Drozda, director of outcomes research, touts the benefits of FDA-approved UDIs for tracking implanted medical devices.
"It’s time for hospitals across the country to reap the benefits of integrating UDI into their supply chains and electronic health records (EHRs)," writes Dr. Drozda, along with Josh Rising, MD, director of health care programs at The Pew Charitable Trusts.
In 2012, Dr. Drozda oversaw the implementation of the cost-cutting and time-saving initiative, tracking coronary artery stents into inventory management, supply chain, billing and EHRs.
Dr. Drozda writes, “researchers at Mercy were able to analyze their data and better understand differences in patient outcomes based on the type of stent implanted – a finding that will help doctors make more informed decisions on what product is most appropriate for each individual.” Click here to read the full article.
Mercy Cardiologist’s Work in National Spotlight
Mercy Spotlighted by one of World’s Largest Charitable Foundations
Drozda Leads Big Five and Headlines Major Medical Journals
Mercy Recognized as Tech Brainiac for Innovation